The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...

People with reduced kidney function may have higher levels of several blood markers commonly used in Alzheimer’s disease research, according to a large new review published in the Journal of the ...

Lower kidney function is associated with elevated Alzheimer’s blood biomarkers, raising implications for dementia diagnosis ...

“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their yearly physicals. There’s another marker in the blood that may be a better ...

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...

A telehealth company that generated buzz last year with a defiant Super Bowl ad hawking weight-loss drugs is back for this year’s championship with a socially charged pitch around longevity. “Rich ...

A new screening test is in clinical trials in New Orleans that can find hidden cancer in your body. A Northshore man who joined the free study says it changed the course of his life. “I feel like I ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off data for a potential FDA approval. Galleri works as a simple blood test that ...

NEW YORK – With blood-based Alzheimer's testing increasingly being used to evaluate patients with signs of cognitive decline, researchers and diagnostics developers have begun exploring the assays' ...